Paper31258425
Curative Therapies for Sickle Cell Disease.
Khemani K and 2 others. Ochsner J, 2019. Cited by 27 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Curative Therapies for Sickle Cell Disease. Papers, record 31258425. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31258425
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References47
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10,706,855 | Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report. Multicenter investigation of bone marrow transplantation for sickle cell disease. | Blood | 2000 | https://conductscience.org/library/papers/10706855 | PubMed |
| 2 | 11,607,766 | Allogeneic stem cell transplantation for sickle cell disease. A study of patients' decisions. | Bone Marrow Transplant | 2001 | https://conductscience.org/library/papers/11607766 | PubMed |
| 3 | 12,424,197 | Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease. | Blood | 2003 | https://conductscience.org/library/papers/12424197 | PubMed |
| 4 | 136,605 | Marrow transplantation for treatment of aplastic anemia. An analysis of factors associated with graft rejection. | N Engl J Med | 1977 | https://conductscience.org/library/papers/136605 | PubMed |
| 5 | 17,250,455 | Hematopoietic cell transplantation for sickle cell disease: state of the art. | Expert Opin Biol Ther | 2007 | https://conductscience.org/library/papers/17250455 | PubMed |
| 6 | 17,560,447 | Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. | Lancet | 2007 | https://conductscience.org/library/papers/17560447 | PubMed |
| 7 | 17,606,762 | Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease. | Blood | 2007 | https://conductscience.org/library/papers/17606762 | PubMed |
| 8 | 17,910,640 | Mixed haematopoietic chimerism for sickle cell disease prevents intravascular haemolysis. | Br J Haematol | 2007 | https://conductscience.org/library/papers/17910640 | PubMed |
| 9 | 18,489,989 | HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. | Biol Blood Marrow Transplant | 2008 | https://conductscience.org/library/papers/18489989 | PubMed |
| 10 | 18,640,578 | Paucity of HLA-identical unrelated donors for African-Americans with hematologic malignancies: the need for new donor options. | Biol Blood Marrow Transplant | 2008 | https://conductscience.org/library/papers/18640578 | PubMed |
| 11 | 18,721,780 | National marrow donor program HLA matching guidelines for unrelated adult donor hematopoietic cell transplants. | Biol Blood Marrow Transplant | 2008 | https://conductscience.org/library/papers/18721780 | PubMed |
| 12 | 19,074,070 | Late pulmonary, cardiovascular, and renal complications after hematopoietic stem cell transplantation and recommended screening practices. | Hematology Am Soc Hematol Educ Program | 2008 | https://conductscience.org/library/papers/19074070 | PubMed |
| 13 | 19,822,218 | Pulmonary, gonadal, and central nervous system status after bone marrow transplantation for sickle cell disease. | Biol Blood Marrow Transplant | 2010 | https://conductscience.org/library/papers/19822218 | PubMed |
| 14 | 19,903,897 | The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS). | Blood | 2010 | https://conductscience.org/library/papers/19903897 | PubMed |
| 15 | 20,331,952 | Population estimates of sickle cell disease in the U.S. | Am J Prev Med | 2010 | https://conductscience.org/library/papers/20331952 | PubMed |
| 16 | 20,513,116 | The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: A 17.5 year follow-up. | Am J Hematol | 2010 | https://conductscience.org/library/papers/20513116 | PubMed |
| 17 | 20,940,417 | Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease. | Blood | 2011 | https://conductscience.org/library/papers/20940417 | PubMed |
| 18 | 21,139,309 | The seventh sickle cell nephropathy. | Intern Med | 2010 | https://conductscience.org/library/papers/21139309 | PubMed |
| 19 | 21,264,908 | Health-related quality of life in adults with sickle cell disease (SCD): a report from the comprehensive sickle cell centers clinical trial consortium. | Am J Hematol | 2011 | https://conductscience.org/library/papers/21264908 | PubMed |
| 20 | 21,277,376 | Umbilical cord blood transplantation for children with thalassemia and sickle cell disease. | Biol Blood Marrow Transplant | 2011 | https://conductscience.org/library/papers/21277376 | PubMed |
Cited by16
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,486,917 | Nonmyeloablative and reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation in sickle cell disease: a narrative review of safety, engraftment, and graft-versus-host-disease outcomes in adults and high-risk populations. | Bone Marrow Transplant | 2026 | https://conductscience.org/library/papers/42486917 | PubMed |
| 41,387,179 | Unravelling the Immunological Enigma of Sickle Cell Disease: Current Understanding and Future Directions. | Immunology | 2026 | https://conductscience.org/library/papers/41387179 | PubMed |
| 41,211,267 | Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Cas Unleashed: Transforming Gene Editing With Breakthroughs, Applications, and Ethical Dilemmas. | Cureus | 2025 | https://conductscience.org/library/papers/41211267 | PubMed |
| 40,311,069 | Use of the microfluidic impedance red cell assay in sickle cell disease. | Blood Adv | 2025 | https://conductscience.org/library/papers/40311069 | PubMed |
| 39,705,613 | Cerebral Hemodynamic Responses to Disease-Modifying and Curative Sickle Cell Disease Therapies. | Neurology | 2025 | https://conductscience.org/library/papers/39705613 | PubMed |
| 39,701,291 | Lipid Levels Increase to the Normal Range After Nonmyeloablative Hematopoietic Cell Transplantation for Sickle Cell Disease. | Transplant Cell Ther | 2025 | https://conductscience.org/library/papers/39701291 | PubMed |
| 39,443,591 | Development of a quantitative prediction algorithm for human cord blood-derived CD34+ hematopoietic stem-progenitor cells using parametric and non-parametric machine learning models. | Sci Rep | 2024 | https://conductscience.org/library/papers/39443591 | PubMed |
| 39,414,860 | Zinc finger nuclease-mediated gene editing in hematopoietic stem cells results in reactivation of fetal hemoglobin in sickle cell disease. | Sci Rep | 2024 | https://conductscience.org/library/papers/39414860 | PubMed |
| 39,359,845 | Advancing life: innovative approaches to enhance survival in sickle cell anemia patients. | Ann Med Surg (Lond) | 2024 | https://conductscience.org/library/papers/39359845 | PubMed |
| 38,972,510 | Reproductive Health Assessment and Reports of Fertility Counseling in Pediatric and Adolescent Patients with Sickle Cell Disease After Hematopoietic Cell Transplantation. | Transplant Cell Ther | 2024 | https://conductscience.org/library/papers/38972510 | PubMed |
| 37,082,003 | Managing the Cerebrovascular Complications of Sickle Cell Disease: Current Perspectives. | J Blood Med | 2023 | https://conductscience.org/library/papers/37082003 | PubMed |
| 37,069,266 | Ex vivo prime editing of patient haematopoietic stem cells rescues sickle-cell disease phenotypes after engraftment in mice. | Nat Biomed Eng | 2023 | https://conductscience.org/library/papers/37069266 | PubMed |
| 36,399,071 | Kruppel-like factor 1-GATA1 fusion protein improves the sickle cell disease phenotype in mice both in vitro and in vivo. | Blood | 2022 | https://conductscience.org/library/papers/36399071 | PubMed |
| 34,200,975 | Cell and Gene Therapy for Anemia: Hematopoietic Stem Cells and Gene Editing. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34200975 | PubMed |
| 33,407,701 | Bone fragility in patients affected by congenital diseases non skeletal in origin. | Orphanet J Rare Dis | 2021 | https://conductscience.org/library/papers/33407701 | PubMed |
| 33,213,986 | Getting blood out of a stone: Identification and management of patients with poor hematopoietic cell mobilization. | Blood Rev | 2021 | https://conductscience.org/library/papers/33213986 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31258425
GET https://conductscience.org/api/papers/v1/31258425/references?page=2